blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1214092

EP1214092 - METHOD OF POTENTIATING CHEMOTHERAPY AND TREATING SOLID TUMORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.10.2003
Database last updated on 24.08.2024
Most recent event   Tooltip24.10.2003Application deemed to be withdrawnpublished on 10.12.2003  [2003/50]
Applicant(s)For all designated states
Wyeth
Five Giralda Farms
Madison, NJ 07940-0874 / US
[N/P]
Former [2002/25]For all designated states
Wyeth
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Inventor(s)01 / GIBBONS, James, Joseph, Jr.
33 Terrace Drive
Westwood, NJ 07675 / US
02 / DUKART, Gary
1714 Benjamin Drive
Ambler, PA 19002 / US
03 / LUCAS, Judy
20 Azalea Drive
Nanuet, NY 10954 / US
04 / SPEICHER, Lisa, Anne
509 Covington Road
Havertown, PA 19083 / US
 [2002/25]
Representative(s)Wileman, David Francis, et al
C/o Wyeth Laboratories Huntercombe Lane South Taplow Maidenhead
Berkshire SL6 OPH / GB
[N/P]
Former [2002/25]Wileman, David Francis, Dr., et al
c/o Wyeth Laboratories Huntercombe Lane South
Taplow Maidenhead Berkshire SL6 OPH / GB
Application number, filing date00961841.412.09.2000
[2002/25]
WO2000US25008
Priority number, dateUS1999039605115.09.1999         Original published format: US 396051
[2002/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0119399
Date:22.03.2001
Language:EN
[2001/12]
Type: A2 Application without search report 
No.:EP1214092
Date:19.06.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 22.03.2001 takes the place of the publication of the European patent application.
[2002/25]
Search report(s)International search report - published on:EP13.12.2001
ClassificationIPC:A61K45/06, A61K31/335, A61K31/475, A61K31/365, A61K31/40, A61K33/24, A61K38/14, A61P35/00
[2002/25]
CPC:
A61K45/06 (EP); A61K33/243 (EP,US); A61K38/04 (EP);
A61K38/05 (EP); A61P35/00 (EP)
C-Set:
A61K31/335, A61K31/28, A61K31/195 (EP);
A61K33/24, A61K31/335, A61K31/195 (EP);
A61K38/04, A61K2300/00 (EP);
A61K38/04, A61K31/28 (EP);
A61K38/04, A61K31/335 (EP);
A61K38/04, A61K33/24 (EP);
A61K38/05, A61K2300/00 (EP);
A61K38/05, A61K31/28 (EP);
A61K38/05, A61K31/335 (EP);
A61K38/05, A61K33/24 (EP)
(-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/25]
Extension statesAL01.03.2002
LT01.03.2002
LV01.03.2002
MKNot yet paid
RO01.03.2002
SI01.03.2002
TitleGerman:VERFAHREN ZUR VERSTÄRKUNG DER CHEMOTHERAPIE UND BEHANDLUNG VON FESTEN TUMOREN[2002/25]
English:METHOD OF POTENTIATING CHEMOTHERAPY AND TREATING SOLID TUMORS[2002/25]
French:PROCEDE DE POTENTIALISATION DE LA CHIMIOTHERAPIE ET DE TRAITEMENT DE TUMEURS SOLIDES[2002/25]
Entry into regional phase01.03.2002National basic fee paid 
01.03.2002Designation fee(s) paid 
01.03.2002Examination fee paid 
Examination procedure04.04.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.03.2002Amendment by applicant (claims and/or description)
01.03.2002Examination requested  [2002/25]
22.11.2002Despatch of a communication from the examining division (Time limit: M06)
03.06.2003Application deemed to be withdrawn, date of legal effect  [2003/50]
07.07.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2003/50]
Fees paidRenewal fee
05.09.2002Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9942099  (DOVETAIL TECHNOLOGIES INC [US], et al) [A] 1-3,6-10,13-17,20-22 * claims 1-4,14 * * page 7, line 24 - page 8, line 11 * * page 12, lines 10-15 *;
 [PX]WO0038665  (SEARLE & CO [US], et al) [PX] 1-4,6-11,13-18,20-22 * claims 1-3,5,6,8,9,22,29-31,36,48,49 * * page 9, line 1 - page 10, line 7 * * page 38, lines 3-7 *;
 [X]  - P.KIER, "high-dose chemotherapy and autologous stem-cell transplantation in breast cancer", ACTA MEDICA AUSTRIACA, (2000), vol. 27, no. suppl.52, pages 33 - 36, XP001009709 [X] 1-3,9,10,16,17 * page 33 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.